113 related articles for article (PubMed ID: 11781710)
1. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
Vockerodt M; Tesch H; Kube D
Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
[TBL] [Abstract][Full Text] [Related]
2. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
Chen H; Lee JM; Zong Y; Borowitz M; Ng MH; Ambinder RF; Hayward SD
J Virol; 2001 Mar; 75(6):2929-37. PubMed ID: 11222718
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.
Cerimele F; Battle T; Lynch R; Frank DA; Murad E; Cohen C; Macaron N; Sixbey J; Smith K; Watnick RS; Eliopoulos A; Shehata B; Arbiser JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):175-9. PubMed ID: 15611471
[TBL] [Abstract][Full Text] [Related]
4. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1.
Yoshizaki T; Sato H; Furukawa M; Pagano JS
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3621-6. PubMed ID: 9520415
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma.
Maesako Y; Uchiyama T; Ohno H
Cancer Sci; 2003 Sep; 94(9):774-81. PubMed ID: 12967475
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.
Ma Y; Walsh MJ; Bernhardt K; Ashbaugh CW; Trudeau SJ; Ashbaugh IY; Jiang S; Jiang C; Zhao B; Root DE; Doench JG; Gewurz BE
Cell Host Microbe; 2017 May; 21(5):580-591.e7. PubMed ID: 28494239
[TBL] [Abstract][Full Text] [Related]
7. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.
Smith N; Tierney R; Wei W; Vockerodt M; Murray PG; Woodman CB; Rowe M
PLoS One; 2013; 8(5):e64868. PubMed ID: 23724103
[TBL] [Abstract][Full Text] [Related]
8. Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection.
Maroui MA; Odongo GA; Mundo L; Manara F; Mure F; Fusil F; Jay A; Gheit T; Michailidis TM; Ferrara D; Leoncini L; Murray P; Manet E; Ohlmann T; De Boevre M; De Saeger S; Cosset FL; Lazzi S; Accardi R; Herceg Z; Gruffat H; Khoueiry R
Proc Natl Acad Sci U S A; 2024 Apr; 121(16):e2314426121. PubMed ID: 38574017
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence.
Bakkalci D; Jia Y; Winter JR; Lewis JE; Taylor GS; Stagg HR
J Glob Health; 2020 Jun; 10(1):010405. PubMed ID: 32257153
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex.
Giehler F; Ostertag MS; Sommermann T; Weidl D; Sterz KR; Kutz H; Moosmann A; Feller SM; Geerlof A; Biesinger B; Popowicz GM; Kirchmair J; Kieser A
Nat Commun; 2024 Jan; 15(1):414. PubMed ID: 38195569
[TBL] [Abstract][Full Text] [Related]
11. Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells.
Fitzsimmons L; Boyce AJ; Wei W; Chang C; Croom-Carter D; Tierney RJ; Herold MJ; Bell AI; Strasser A; Kelly GL; Rowe M
Cell Death Differ; 2018 Feb; 25(2):241-254. PubMed ID: 28960205
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and Burkitt lymphoma.
Rowe M; Fitzsimmons L; Bell AI
Chin J Cancer; 2014 Dec; 33(12):609-19. PubMed ID: 25418195
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1α.
Incrocci R; Monroy Del Toro R; Devitt G; Salimian M; Braich K; Swanson-Mungerson M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612754
[TBL] [Abstract][Full Text] [Related]
14. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis.
Samanta M; Takada K
Cancer Sci; 2010 Jan; 101(1):29-35. PubMed ID: 19886912
[TBL] [Abstract][Full Text] [Related]
15. EPSTEIN -BARR VIRUS ASSOCIATION WITH MALIGNANT LYMPHOMA SUBGROUPS IN ZARIA, NIGERIA.
Iliyasu Y; Ayers LW; Liman AA; Waziri GD; Shehu SM
Niger J Surg Sci; 2014; 23(1):6-8. PubMed ID: 25620871
[TBL] [Abstract][Full Text] [Related]
16. Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells.
Sharma S; Sauer T; Omer BA; Shum T; Rollins LA; Rooney CM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958791
[TBL] [Abstract][Full Text] [Related]
17. Understanding the role of membrane cholesterol upon Epstein Barr virus infection in astroglial cells.
Rani A; Tanwar M; Verma TP; Patra P; Trivedi P; Kumar R; Jha HC
Front Immunol; 2023; 14():1192032. PubMed ID: 37876925
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment.
Teow SY; Yap HY; Peh SC
J Pathog; 2017; 2017():7349268. PubMed ID: 29464124
[TBL] [Abstract][Full Text] [Related]
19. Letter: Burkitt's lymphoma in a patient treated for Hodgkin's disease: one or two diseases?
Sartiano GP
N Engl J Med; 1975 Jun; 292(25):1353. PubMed ID: 165412
[No Abstract] [Full Text] [Related]
20. An Atypical Presentation of Burkitt Lymphoma Presenting As Large Intra-abdominal Masses Compressing Multiple Organs With Peri-Pericardial Involvement in an HIV Patient: A Case Report and Literature Review.
Ugwendum D; Fernando A; Arrey Agbor DB; Ndemazie NB; Forsah SF; Okorie IJ; Villanueva K; Grigos A; Nfonoyim J
Cureus; 2024 Feb; 16(2):e54088. PubMed ID: 38487136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
